General Information of the Compound
| Compound ID |
CP0225239
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[2-(cyclopropanecarbonylamino)pyridin-4-yl]-4-[2-[1-[(2,6-difluorophenyl)methyl]piperidin-4-yl]ethoxy]-1,3-thiazole-5-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H29F2N5O3S
|
||||||||||||||||||
| Molecular Weight |
541.624
|
||||||||||||||||||
| Canonical SMILES |
NC(=O)c1sc(nc1OCCC1CCN(Cc2c(F)cccc2F)CC1)-c1ccnc(NC(=O)C2CC2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H29F2N5O3S/c28-20-2-1-3-21(29)19(20)15-34-11-7-16(8-12-34)9-13-37-26-23(24(30)35)38-27(33-26)18-6-10-31-22(14-18)32-25(36)17-4-5-17/h1-3,6,10,14,16-17H,4-5,7-9,11-13,15H2,(H2,30,35)(H,31,32,36)
Show/Hide
|
||||||||||||||||||
| InChIKey |
YZWHKDPJXRQPRD-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00820, Acetylcholinesterase
Protein ID: PT00962, Glycogen synthase kinase-3 beta